CSPC PHARMACEUTICAL
CSPCY (CSPC PHARMACEUTICAL) is held by 2 institutional investors as of Q2 2026. Top institutional shareholders: RhumbLine Advisers ($6,894), PNC Financial Services Group, Inc. ($505).
Who's Trading
Source dates: Price Nov 5, 2026 · Insiders none · Activists none · Congress none
No recent insider, activist, or congressional trades for CSPCY.
Top Holders
| Action | ||||||
|---|---|---|---|---|---|---|
Unchanged | 1,965 | $6,894 | 0.0% | — | 0 | |
Unchanged | 144 | $505 | 0.0% | — | 0 |
CSPCYCSPC PHARMACEUTICALContinue exploring
Other Healthcare stocks held by institutions
UNHUnitedHealth Group Incorporated
LLYEli Lilly and Company
TMOThermo Fisher Scientific Inc
JNJJohnson & Johnson
DHRDanaher Corporation
ISRGIntuitive Surgical, Inc.
MRKMerck & Company, Inc.
ABBVAbbVie Inc.
BSXBoston Scientific Corporation
ABTAbbott LaboratoriesQuestions investors ask about CSPCY
Who owns CSPCY?
2 institutional investors held CSPCY on June 30, 2026, led by RhumbLine Advisers ($6,894) and PNC Financial Services Group, Inc. ($505).
How many hedge funds hold CSPCY?
2 institutional investors reported CSPCY in their 13F filings for the quarter ended June 30, 2026, $7,399 in all. One of them is rated Elite.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer